Michael Baseler

24.2k total citations · 7 hit papers
99 papers, 17.1k citations indexed

About

Michael Baseler is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Michael Baseler has authored 99 papers receiving a total of 17.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Immunology, 54 papers in Virology and 31 papers in Infectious Diseases. Recurrent topics in Michael Baseler's work include HIV Research and Treatment (54 papers), Immune Cell Function and Interaction (51 papers) and T-cell and B-cell Immunology (24 papers). Michael Baseler is often cited by papers focused on HIV Research and Treatment (54 papers), Immune Cell Function and Interaction (51 papers) and T-cell and B-cell Immunology (24 papers). Michael Baseler collaborates with scholars based in United States, Australia and Poland. Michael Baseler's co-authors include H. Clifford Lane, Brad T. Sherman, Richard A. Lempicki, Xiaoli Jiao, Anthony S. Fauci, Tomozumi Imamichi, Ju Qiu, Weizhong Chang, Ming Hao and Da Wei Huang and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael Baseler

99 papers receiving 16.8k citations

Hit Papers

DAVID: ... 1989 2026 2001 2013 2022 2007 2007 1997 2012 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Baseler United States 48 6.0k 6.0k 5.6k 3.6k 2.7k 99 17.1k
Arnold B. Rabson United States 51 5.1k 0.8× 3.9k 0.7× 3.8k 0.7× 2.8k 0.8× 1.9k 0.7× 123 12.2k
C A Rosen United States 66 6.5k 1.1× 8.3k 1.4× 7.0k 1.3× 3.2k 0.9× 2.4k 0.9× 108 20.2k
Kendall A. Smith United States 55 2.2k 0.4× 3.9k 0.6× 11.8k 2.1× 1.8k 0.5× 1.7k 0.6× 143 18.6k
Leonore A. Herzenberg United States 81 1.5k 0.2× 6.2k 1.0× 10.1k 1.8× 1.2k 0.3× 1.7k 0.6× 202 20.1k
Hui Zhang China 50 2.6k 0.4× 4.8k 0.8× 2.8k 0.5× 2.3k 0.6× 1.9k 0.7× 276 10.2k
Michael G. Katze United States 91 2.1k 0.4× 10.9k 1.8× 10.2k 1.8× 6.8k 1.9× 9.7k 3.6× 300 27.8k
Herbert C. Morse United States 81 2.3k 0.4× 8.0k 1.3× 12.1k 2.2× 1.4k 0.4× 2.8k 1.1× 437 22.8k
Dennis D. Taub United States 76 1.4k 0.2× 4.5k 0.7× 7.5k 1.4× 739 0.2× 2.3k 0.9× 235 17.9k
Aftab A. Ansari United States 78 1.9k 0.3× 2.2k 0.4× 6.3k 1.1× 2.2k 0.6× 7.0k 2.6× 436 21.0k
Ming Li China 55 1.6k 0.3× 4.4k 0.7× 2.0k 0.4× 1.1k 0.3× 950 0.4× 387 10.0k

Countries citing papers authored by Michael Baseler

Since Specialization
Citations

This map shows the geographic impact of Michael Baseler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Baseler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Baseler more than expected).

Fields of papers citing papers by Michael Baseler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Baseler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Baseler. The network helps show where Michael Baseler may publish in the future.

Co-authorship network of co-authors of Michael Baseler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Baseler. A scholar is included among the top collaborators of Michael Baseler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Baseler. Michael Baseler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imamichi, Tomozumi, Xing Zhang, Ming Zhou, et al.. (2011). Ku70 is a novel cytosolic DNA sensor that induces a Type-III rather than Type-I IFN via activation of IRF-1 and IRF-7. (116.11). The Journal of Immunology. 186(1_Supplement). 116.11–116.11. 1 indexed citations
2.
Pascal, Véronique, Eriko Yamada, Maureen P. Martin, et al.. (2007). Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection. The Journal of Immunology. 179(3). 1625–1633. 43 indexed citations
3.
Sherman, Brad T., Da Wei Huang, Yongjian Guo, et al.. (2007). DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics. 8(1). 426–426. 440 indexed citations
4.
Shafer-Weaver, Kimberly, et al.. (2005). A Novel Flow Cytometric Assay for Evaluating Cell-Mediated Cytotoxicity. Journal of Immunotherapy. 28(4). 396–402. 41 indexed citations
5.
Strobl, Susan, Sattva S. Neelapu, Kimberly Shafer-Weaver, et al.. (2004). A modified IFN-γ ELISPOT assay to detect specific responses to human primary tumor cells. Cancer Research. 64. 283–283. 1 indexed citations
6.
Tavel, Jorge A., Irini Sereti, Robert Walker, et al.. (2003). A Randomized, Double‐Blinded, Placebo‐Controlled Trial of Intermittent Administration of Interleukin‐2 and Prednisone in Subjects Infected with Human Immunodeficiency Virus. The Journal of Infectious Diseases. 188(4). 531–536. 12 indexed citations
7.
Pinto, Lígia A., Philip E. Castle, Clayton Harro, et al.. (2003). Cellular Immune Responses to Human Papillomavirus (HPV)–16 L1 in Healthy Volunteers Immunized with Recombinant HPV‐16 L1 Virus‐Like Particles. The Journal of Infectious Diseases. 188(2). 327–338. 140 indexed citations
8.
Moir, Susan, Angela Malaspina, Kisani M. Ogwaro, et al.. (2001). HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proceedings of the National Academy of Sciences. 98(18). 10362–10367. 242 indexed citations
9.
Douek, Daniel C., Michael R. Betts, Brenna J. Hill, et al.. (2001). Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection. The Journal of Immunology. 167(11). 6663–6668. 192 indexed citations
10.
Dybul, Mark, Tae‐Wook Chun, Christian Yoder, et al.. (2001). Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters. Proceedings of the National Academy of Sciences. 98(26). 15161–15166. 111 indexed citations
11.
Derby, Eric, et al.. (2001). Flow Cytometric Assay for the Simultaneous Analysis of Cell-Mediated Cytotoxicity and Effector Cell Phenotype. BioTechniques. 31(3). 660–665. 11 indexed citations
12.
Kovacs, Joseph A., Hiromi Imamichi, Susan Vogel, et al.. (2000). Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression. The Journal of Infectious Diseases. 182(4). 1063–1069. 25 indexed citations
13.
Gea‐Banacloche, Juan, JoAnn M. Mican, Claire W. Hallahan, et al.. (2000). Longitudinal Changes in CD4 + T Cell Antigen Receptor Diversity and Naive/Memory Cell Phenotype during 9 to 26 Months of Antiretroviral Therapy of HIV-Infected Patients. AIDS Research and Human Retroviruses. 16(17). 1877–1886. 21 indexed citations
14.
Davey, Richard T., Doreen Chaitt, Jeffrey M. Albert, et al.. (1999). A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 179(4). 849–858. 112 indexed citations
15.
Walker, Robert, Gerald D. Kelly, R. V. McCloskey, et al.. (1996). Inhibition of Immunoreactive Tumor Necrosis Factor-  by a Chimeric Antibody in Patients Infected with Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 174(1). 63–68. 60 indexed citations
16.
Kovacs, Joseph A., M. B. Vasudevachari, Richard T. Davey, et al.. (1993). Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.. Journal of Clinical Investigation. 92(2). 919–928. 32 indexed citations
17.
Koenig, Scott, Robert M. Woods, Yambasu A. Brewah, et al.. (1993). Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.. The Journal of Immunology. 151(7). 3874–3883. 85 indexed citations
18.
Perno, Carlo Federico, Michael Baseler, S Broder, & Robert Yarchoan. (1990). Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.. The Journal of Experimental Medicine. 171(4). 1043–1056. 62 indexed citations
19.
Veltri, Robert W., et al.. (1986). A new class of synthetic biological response modifiers: the methylfurylbutyrolactones (Nafocare B).. PubMed. 5(5). 444–61. 7 indexed citations
20.
Baseler, Michael, Peter E. Maxim, & Robert W. Veltri. (1984). Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancer. Federation Proceedings. 43(6). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026